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Longitudinal melanonychia can be caused by melanocyte activation (hypermelanosis) or proliferation (lentigo, nevus or
melanoma). Histopathologic examination is mandatory for suspicious cases of melanomas. Tangential biopsy of the matrix is
an elegant technique avoiding nail plate dystrophy, but it was unknown whether the depth of the sample obtained by this method
isadequateforhistopathologicdiagnosis.Twenty-twopatientswithlongitudinalmelanonychiastriataweresubmittedtotangential
matrixbiopsiesdescribedbyHaneke.Thetissuewasstainedwithhematoxylin-eosinandthespecimensweremeasuredat3distinct
points according to the total thickness: largest (A), intermediate (B) and narrowest (C) then divided into 4 groups according to
the histopathologic diagnosis (G1: hypermelanosis; G2: lentigos; G3: nevus; G4: melanoma). The lesions were measured using the
same method. The mean specimen/lesion thickness measure values for each group was: G1: 0,59/0,10mm, G2: 0,67/0,08mm, G3:
0,52/0,05mm, G4: 0,58/0,10mm. The general average thickness for all the specimens/lesions was 0,59/0,08mm. We concluded
that the tangential excision, for longitudinal melanonychia, provides an adequate material for histopathological diagnosis.
1.Introduction
The longitudinal melanonychia can be caused by activa-
tion (hypermelanosis) or melanocytic proliferation (lentigo,
nevus,ormelanoma).Thediagnosticaccuracyofmelanomas
presenting as longitudinal melanonychia is low among der-
matologists [1]. Thus, biopsy of suspect cases is mandatory.
Of all the diﬀerential diagnoses [2], melanoma is the more
concerning [3, 4]. Among the many techniques in the
literature [5–8], the tangential biopsy of the matrix [9]
is an elegant alternative providing adequate samples for
histopathologic analysis [10], as well as excellent cosmetic
results. However, there is still question if the depth of the
sample obtained by this method is adequate for histopatho-
logic diagnosis.
The goal of this pilot study is to demonstrate that the
tangential biopsy of the matrix provides adequate specimens
for the pathologist diagnosis in patients with melanonychia
striata.
1.1. Material and Methods. Twenty-two cases of longitu-
dinal melanonychia underwent matrix tangential biopsy
between February 2008 and November 2010. Patients with
melanonychia striata were included. Exclusion criteria were
presence of Hutchinson’s sing and onychodystrophy. All the
biopsies were performed by the same senior dermatologic
surgeon based on the technique described by Haneke and
Baran [9] (Figures 1 and 2). After distal wing block of
the ﬁnger, 2 oblique incisions were made at the proximal
nail fold allowing to reﬂect it and expose the proximal
nail plate. The proximal third of the nail plate is then
carefully avulsed granting direct visualization of the matrix
and the melanocytic lesion. Polarized dermoscopy was used2 Dermatology Research and Practice
Figure 1: Incision around the pigmented lesion.
Figure 2: Matrix after tangential excision.
during the procedure to determine the lateral margins of
the lesion where gentle incisions are made. The specimen
was then removed by tangential incision, placed on a piece
of paper, and sent to the lab in a formalin jar. The tissue
was stained with hematoxylin-eosin and analysed by the
samedermatopathologistexpertinhistopathologyofthenail
apparatus. Using a microscope microruler, the specimens
were measured at 3 distinct points according to the total
thickness: largest: A, intermediate: B, and narrowest: C
(Figure 3). The lesions depth was measured with the same
method (Figure 4). The data was divided in 4 groups accord-
ing to the histopathologic diagnosis: G1: hypermelanosis,
G2: lentigo, G3: nevus, and G4: melanoma. The mean
thickness values found in A, B, and C were calculated (MA,
MB, and MC) for the specimens and lesions. The average
value of the measures MA, MB, and MC (MABC) for each
specimenandlesionwasalsocalculated,aswellasthegeneral
average values for all specimens (MGe) and lesions (MGl)
thickness.
2. Results
The mean specimen/lesion thickness measure values
(MABC) for each group were: G1: 0.59/0,10mm, G2:
0.67/0,08mm, G3: 0.52/0,05mm, and G4: 0.58/0,10mm.
Table 1: Average thickness measures.
Diagnosis Specimens Lesions
Hypermelanosis (G1)
(n = 14)
MA: 0.71mm MA: 0.11mm
MB: 0.54mm MB: 0.10mm
MC: 0.53mm MC: 0.09mm
Average: 0.59mm Average: 0.10mm
Lentigo (G2) (n = 1)
MA: 0.9mm MA: 0.1mm
MB: 0.6mm MB: 0.08mm
MC: 0.5mm MC: 0.06mm
MABC: 0,67mm MABC: 0.08mm
Nevus (G3) (n = 6)
MA: 0.65mm MA: 0.07mm
MB: 0.47mm MB: 0.05mm
MC: 0.45mm MC: 0.04mm
MABC: 0.52mm MABC: 0.05mm
Melanoma (G4) (n = 1)
MA: 0.68mm MA: 0.12mm
MB: 0.56mm MB: 0.10mm
MC: 0.51mm MC: 0.09mm
MABC: 0.58mm MABC: 0.10mm
General average (n = 22) MGs:0.59mm MGl: 0.08mm
B A
C
Figure 3: Specimen thickness measure points: largest: A, interme-
diate: B, and narrowest: C.
The general average thickness for all the lesions (MGs/MGl)
was 0.59/0,08mm (Table 1).
3. Discussion
The longitudinal melanonychia is described as a brown
or black linear macule caused by melanocytic activation
or proliferation. In melanocytic activation, the number of
melanocytes is normal but with an increased pigment pro-
duction. On the other hand, in the melanocytic proliferation
there is an increased number of melanocytes as well as
pigmentproduction.Thisgroupincludesbenignhyperplasia
(lentigo), nevus, and melanoma [2].Dermatology Research and Practice 3
   
Figure 4: Lesion thickness measure points: largest: A, intermediate:
B, and narrowest: C.
Figure 5: Longitudinal melanonychia.
Figure 6: The same patient 9 months after tangential biopsy.
Early diagnosis of nail apparatus melanoma remains a
challenge, even among experienced dermatologists [1, 11].
The ABCDEF [12] rule is intended to facilitate the clinical
detection of subungual melanoma, but it has limitations.
Dermoscopy of the nail plate helps determinate if the
pigment is melanic or not [2]; however, it is not as useful for
proliferative melanonychia diﬀerentiation. Intraoperative
dermoscopic criteria were proposed to set apart melanocytic
activation from proliferation, as well as benign from malig-
nant proliferation [13, 14]. Despite all these methods,
the histopathologic exam remains the gold standard for
melanonychia. Therefore, biopsy in suspected cases is
mandatory.
The histopathological alterations in hypermelanosis,
lentigo, and nevus are restricted to the epidermis or upper
dermis.Theauthorsobservedthatwhenmelanomasareclin-
ically presented as longitudinal melanonychia they usually
are in situ or microinvasive.
Jellinek recently reviewed and described the biopsy tech-
niques for melanonychia [10]. Lateral longitudinal excision
and full thickness excision allow complete removal of the
melanocytic lesion, but nail plate dystrophy may occur.
When the 3mm punch is used, dystrophy can also be
observed, specially with children where the ﬁngers are small.
Besides, a 3mm punch may not remove the whole lesion. All
the specimens obtained by these methods is adequate for an
accurate histopathological diagnosis. The tangential biopsy,
described by Haneke and Baran [9], permits to completely
remove the lesion without permanent dystrophy. However,
there are no current studies indicating if the thickness of
the excised specimens is adequate for the histopathological
diagnosis.
In this pilot study we observed that the specimens had
an average thickness of 0.59mm, while the histopathological
alterations had an average of 0.08mm. The mean specimen
depth was 7.35 times thicker than the lesion, which is very
adequate for histopathological diagnosis. We also veriﬁed
that the injury to the matrix by the shave biopsy is minimal
and results in more aesthetic outcomes (Figures 5 and 6).
It is important to keep in mind that the dermatologist,
pathologist, and lab technician must be well trained and
familiar with this technique.
Although the tangential biopsy of melanocytic lesions
does not provide a precise Breslow index, melanomas pre-
senting as longitudinal melanonychia are in situ or microin-
vasive. Thus, the Breslow index is not measured.
This pilot study is limited by the fact that only the depth
of the lesions was addressed and it did not control the lateral
aspect. No immunohistochemical analysis was realized. New
studies are being conducted in this direction.
4. Conclusion
Based on the measures obtained of the specimens and pig-
mented lesions thickness, we concluded that the tangential
excision, for longitudinal melanonychia, provides an ade-
quate material for histopathological diagnosis.4 Dermatology Research and Practice
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